Breast cancer is categorized into numerous subgroups based on the countenance of the human epidermal growth factor receptor 2 (HER2), progesterone receptor (PR), or estrogen receptor (ER) (Mahmoud et al. 2023). Here, ERBB2 is linked to breast carcinoma.